Mikkael Sekeres, M.D.

Cleveland Clinic - Taussig Cancer ...Cleveland, Ohio - 44195 Cleveland ClinicCleveland, Ohio - 44195 (216-445-9243) Cleveland Clinic Taussig Cancer Instititute, ...Cleveland, Ohio - 44195 (216-445-9353) Taussig Cancer Center, Cleveland Clinic ...Cleveland, Ohio - 44195 |
- CLINICAL TRIALS 5
- CONDITIONS7
- INTERVENTIONS9
- SINCE2006

Study of Idarubicin + Cytarabine and Lenalidomide in Patients With Myelodysplastic Syndrome (MDS) Acute Myeloid Leukemia (AML)
January 2009 - February 2013

Dose-Ranging Study of Telintra Tablets + Revlimid in Patients With Non-Deletion (5q) Low to Intermediate-1 Risk Myelodysplastic Syndrome (MDS)
November 2009 - May 2012

A Dose Confirmation Study of Oral Clofarabine for Adult Patients Previously Treated for Myelodysplastic Syndromes (MDS)
September 2007 - June 2011

Lenalidomide and Azacitidine in Treating Patients With Advanced Myelodysplastic Syndromes
May 2006 - November 2011

Sirolimus and Cyclosporine for Treatment-Resistant Aplastic Anemia
May 2006 - December 2009
Leukemia
Leukemia, Myeloid, Acute
Leukemia, Myeloid
Myelodysplastic Syndromes
Preleukemia
Anemia
Anemia, Aplastic
Lenalidomide
Cyclosporine
Cytarabine
Lenalidomide (Revlimid®)
Azacitidine
Sirolimus
Clofarabine
Idarubicin
Ezatiostat Hydrochloride



